Low-dose radiation-induced enhancement of thymic lymphomagenesis in lck-bax mice is dependent on LET and gender

Radiation Research

Volumn 180, Issue 2, 2013, Pages 156-165

  Jacobus, James A ^a,f   Duda, Chester G ^b   Coleman, Mitchell C ^a   Martin, Sean M ^a   Mapuskar, Kranti ^a,b   Mao, Gaowei ^a   Smith, Brian J ^b   Aykin Burns, Nukhet ^c   Guida, Peter ^d   Gius, David ^e   Domann, Frederick E ^a   Knudson, C Michael ^a   Spitz, Douglas R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f MINNESOTA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137; IRON; MITOCHONDRIAL PROTEIN; PROTEIN BAX; PROTEIN KINASE LCK; SILICON; SIRTUIN 3; SUPEROXIDE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; DOSE RESPONSE; FEMALE; GENE DOSAGE; LINEAR ENERGY TRANSFER; LOW ENERGY RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; THYMOCYTE; THYMUS LYMPHOMA;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CESIUM RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENE DOSAGE; HEAVY IONS; IRON; LINEAR ENERGY TRANSFER; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); LYMPHOMA; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MITOCHONDRIA; NEOPLASMS, RADIATION-INDUCED; NEOPLASTIC SYNDROMES, HEREDITARY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; RADIATION DOSAGE; RADIATION TOLERANCE; RECOMBINANT FUSION PROTEINS; SEX CHARACTERISTICS; SILICON; SIRTUIN 3; SUPEROXIDES; THYMOCYTES; THYMUS NEOPLASMS; WHOLE-BODY IRRADIATION;

EID: 84882276956     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR3293.1     Document Type: Article

References (50)

1. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956; 11:298-300.
2. Harman D. Prolongation of the normal life span by radiation protection chemicals. J Gerontol 1957; 12:257-63.
3. Harman D. Prolongation of the normal lifespan and inhibition of spontaneous cancer by antioxidants. J Gerontol 1961; 16:247-54.
4. van de Wetering CI, Coleman MC, Spitz DR, Smith BJ, Knudson CM. Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma. Free Radic Biol Med 2008; 44:1677-86.
5. Spitz DR, Azzam EI, Li JJ, Gius D. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying concept in stress response biology. Cancer Metastasis Rev 2004; 23:311-22.
6. Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D, Ogi J, et al. Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 2003; 23:2362-78.
7. Dayal D, Martin SM, Limoli CL, Spitz DR. Hydrogen peroxide mediates the radiation-induced mutator phenotype in mammalian cells. Biochem J 2008; 413:185-91.
8. Jaffe D, Bowden GT. Ionizing radiation as an initiator: Effects of proliferation and promotion time on tumor incidence in mice. Cancer Res 1987; 47:6692-6.
9. St Clair D, Zhao Y, Chaiswing L, Oberley T. Modulation of skin tumorigenesis by SOD. Biomed Pharmacother 2005; 59:209-14.
10. Ron E. Ionizing radiation and cancer risk: Evidence from epidemiology. Radiat Res 1998; 150:S30-41.
11. Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, et al. Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know. Proc Natl Acad Sci USA 2003; 100:13761-6.
12. Richardson DB, Sugiyama H, Wing S, Sakata R, Grant E, Shimizu Y, et al. Positive associations between ionizing radiation and lymphoma mortality among men. Am J Epidemiol 2009; 169:969-76.
13. Boice JD, Jr. Radiation and non-hodgkin's lymphoma. Cancer Res 1992; 52:5489s-91s.
14. Cucinotta FA, Chappell LJ. Updates to astronaut radiation limits: Radiation risks for never-smokers. Radiat Res 2011; 176:102-14.
15. Ponomarev AL, Cucinotta FA. Nuclear fragmentation and the number of particle tracks in tissue. Radiat Prot Dosimetry 2006;122:354-61.
16. Durante M, Cucinotta FA. Heavy ion carcinogenesis and human space exploration. Nat Rev Cancer 2008; 8:465-72.
17. Dziegielewski J, Goetz W, Baulch JE. Heavy ions, radioprotectors and genomic instability: Implications for human space exploration. Radiat Environ Biophys 2010; 49:303-16.
18. Grdina DJ, Murley JS, Kataoka Y, Baker KL, Kunnavakkam R, Coleman MC, et al. Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. Int J Radiat Oncol Biol Phys 2009; 73:886-96.
19. Kim GJ, Chandrasekaran K, Morgan WF. Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: A review. Mutagenesis 2006; 21:361-7.
20. Aykin-Burns N, Slane BG, Liu AT, Owens KM, O'Malley MS, Smith BJ, et al. Sensitivity to low-dose/low-LET ionizing radiation in mammalian cells harboring mutations in succinate dehydrogenase subunit C is governed by mitochondria-derived reactive oxygen species. Radiat Res 2011; 175:150-8.
21. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010; 17:41-52.
22. Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 2010; 40:893-904.
23. Knudson CM, Johnson GM, Lin Y, Korsmeyer SJ. Bax accelerates tumorigenesis in p53-deficient mice. Cancer Res 2001; 61:659-65.
24. Case AJ, McGill JL, Tygrett LT, Shirasawa T, Spitz DR, Waldschmidt TJ, et al. Elevated mitochondrial superoxide disrupts normal T cell development, impairing adaptive immune responses to an influenza challenge. Free Radic Biol Med 2011; 50:448-58.
25. Robinson KM, Janes MS, Pehar M, Monette JS, Ross MF, Hagen TM, et al. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci USA 2006 Oct; 103:15038-43.
26. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989; 179:8-18.
27. Bettega D, Calzolari P, Doneda L, Durante M, Tallone L. Early and delayed reproductive death in human cells exposed to high energy iron ion beams. Adv Space Res 2005; 35:280-5.
28. Wu H, Hada M, Meador J, Hu X, Rusek A, Cucinotta FA. Induction of micronuclei in human fibroblasts across the bragg curve of energetic heavy ions. Radiat Res 2006; 166:583-9.
29. Cucinotta FA, Nikjoo H, Goodhead DT. Model for radial dependence of frequency distributions for energy imparted in nanometer volumes from HZE particles. Radiat Res 2000; 153:459-68.
30. Weil MM, Bedford JS, Bielefeldt-Ohmann H, Ray FA, Genik PC, Ehrhart EJ, et al. Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1 GeV/nucleon (56)fe ions. Radiat Res 2009; 172:213-9.
31. Schimmerling W, Cucinotta FA. Dose and dose rate effectiveness of space radiation. Radiat Prot Dosimetry 2006; 122:349-53.
32. Oberley LW, Buettner GR. Role of superoxide dismutase in cancer: A review. Cancer Res 1979; 39:1141-9.
33. Ridnour LA, Oberley TD, Oberley LW. Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid Redox Signal 2004; 6:501-12.
34. Sun Y, Holley AK, St Clair DK. p53 regulation of energy metabolism and mitochondria regulation of p53 in cancer cells: An insight into the role of manganese superoxide dismutase. Curr Pharm Biotechnol 2013; 4(3):261-73.
35. St Clair DK, Wan XS, Oberley TD, Muse KE, St Clair WH. Suppression of radiation-induced neoplastic transformation by overexpression of mitochondrial superoxide dismutase. Mol Carcinog 1992; 6:238-42.
36. Weydert C, Roling B, Liu J, Hinkhouse MM, Ritchie JM, Oberley LW, et al. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Ther 2003; 2:361-9.
37. Ozden O, Park SH, Kim HS, Jiang H, Coleman MC, Spitz DR, et al. Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress. Aging 2011; 3:102-7.
38. Zhu Y, Kalen AL, Li L, Lehmler HJ, Robertson LW, Goswami PC, et al. Polychlorinated-biphenyl-induced oxidative stress and cytotoxicity can be mitigated by antioxidants after exposure. Free Radic Biol Med 2009; 47:1762-71.
39. Haigis MC, Deng CX, Finley LW, Kim HS, Gius D. SIRT3 is a mitochondrial tumor suppressor: A scientific tale that connects aberrant cellular ROS, the warburg effect, and carcinogenesis. Cancer Res 2012; 72:2468-72.
40. Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL. SIRT3 and cancer: Tumor promoter or suppressor? Biochim Biophys Acta 2011; 1816:80-8.
41. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 2011; 19:416-28.
42. Alhazzazi TY, Kamarajan P, Joo N, Huang JY, Verdin E, D'Silva NJ, et al. Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer 2011; 117:1670-8.
43. Zhang CZ, Liu L, Cai M, Pan Y, Fu J, Cao Y, et al. Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma. PLoS One 2012; 7:e51703.
44. Zhang YY, Zhou LM. Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation. Biochem Biophys Res Commun 2012; 423:26-31.
45. Bell EL, Emerling BM, Ricoult SJ, Guarente L. SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene 2011; 30:2986-96.
46. Li S, Banck M, Mujtaba S, Zhou MM, Sugrue MM, Walsh MJ. p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. PLoS One 2010; 5:e10486.
47. Allison SJ, Milner J. SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle 2007; 6:2669-77.
48. Park SH, Ozden O, Jiang H, Cha YI, Pennington JD, Aykin-Burns N, et al. Sirt3, mitochondrial ROS, ageing, and carcinogenesis. Int J Mol Sci 2011; 12:6226-39.
49. Owens KM, Aykin-Burns N, Dayal D, Coleman MC, Domann FE, Spitz DR. Genomic instability induced by mutant succinate dehydrogenase subunit D (SDHD) is mediated by O2-and H2O2. Free Radic Biol Med 2012; 52:160-6.
50. Slane BG, Aykin-Burns N, Smith BJ, Kalen AL, Goswami PC, Domann FE, et al. Mutation of succinate dehydrogenase subunit C results in increased O2-, oxidative stress, and genomic instability. Cancer Res 2006; 66:7615-20.